These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31147887)

  • 1. Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI.
    Liang J; Cheng Q; Huang J; Ma M; Zhang D; Lei X; Xiao Z; Zhang D; Shi C; Luo L
    Angiogenesis; 2019 Aug; 22(3):457-470. PubMed ID: 31147887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of dynamic MRI in monitoring the microenvironmental changes of anti-vascular therapy in a xenograft model].
    Liang JY; Xiao ZY; Zhang D; Ma MJ; Huang JX; Shi CZ; Luo LP
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):51-56. PubMed ID: 31914559
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
    Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
    J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.
    Liang J; Dai W; Li Z; Liang X; Xiao M; Xie C; Li X
    BMC Cancer; 2022 Oct; 22(1):1033. PubMed ID: 36192709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Treatment Efficacy of Antiangiogenic Therapy Combined With Hypoxia-Activated Prodrugs Online Using Functional MRI.
    Ma M; Liang J; Zhang D; Xu X; Cheng Q; Xiao Z; Shi C; Luo L
    Front Oncol; 2021; 11():672047. PubMed ID: 33996599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment.
    Liang J; Li Z; Li J; Peng C; Dai W; He H; Zeng S; Xie C
    Front Oncol; 2020; 10():1376. PubMed ID: 32974136
    [No Abstract]   [Full Text] [Related]  

  • 7. DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
    Hauge A; Gaustad JV; Huang R; Simonsen TG; Wegner CS; Andersen LMK; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):666-676. PubMed ID: 30858145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.
    Gaustad JV; Simonsen TG; Smistad R; Wegner CS; Andersen LM; Rofstad EK
    BMC Cancer; 2015 Nov; 15():900. PubMed ID: 26573613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
    Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
    Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
    Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling.
    Baker LCJ; Boult JKR; Thomas M; Koehler A; Nayak T; Tessier J; Ooi CH; Birzele F; Belousov A; Zajac M; Horn C; LeFave C; Robinson SP
    Br J Cancer; 2016 Sep; 115(6):691-702. PubMed ID: 27529514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.
    Yopp AC; Schwartz LH; Kemeny N; Gultekin DH; Gönen M; Bamboat Z; Shia J; Haviland D; D'Angelica MI; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR
    Ann Surg Oncol; 2011 Aug; 18(8):2192-9. PubMed ID: 21286939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging for monitoring the anti-angiogenesis efficacy in a C6 glioma rat model.
    Hou W; Li X; Pan H; Xu M; Bi S; Shen Y; Yu Y
    Acta Radiol; 2020 Jul; 61(7):973-982. PubMed ID: 31739674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
    Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
    Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
    Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
    Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.
    Sun X; Yang L; Yan X; Sun Y; Zhao D; Ji Y; Wang K; Chen X; Shen B
    PLoS One; 2016; 11(9):e0162601. PubMed ID: 27632532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.
    Yang J; Liao C; Liu Y; Yang G; Ke T; Ding Y; Li Q
    Oncotarget; 2018 Feb; 9(15):11964-11976. PubMed ID: 29552285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.